受强制性开放获取政策约束的文章 - Dennis Poel, PhD了解详情
可在其他位置公开访问的文章：6 篇
miRNAs: micro-managers of anticancer combination therapies
JR van Beijnum, E Giovannetti, D Poel, P Nowak-Sliwinska, AW Griffioen
Angiogenesis 20, 269-285, 2017
强制性开放获取政策： European Commission, Dutch Cancer Society
Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids
B Subtil, KK Iyer, D Poel, L Bakkerus, MAJ Gorris, JC Escalona, K Dries, ...
Frontiers in immunology 14, 1105244, 2023
强制性开放获取政策： Netherlands Organisation for Scientific Research, European Commission …
Development of a miRNA‐based classifier for detection of colorectal cancer molecular subtypes
RS Adam, D Poel, L Ferreira Moreno, JMA Spronck, TR de Back, ...
Molecular oncology 16 (14), 2693-2709, 2022
强制性开放获取政策： Cancer Research UK, European Commission, Netherlands Organisation for Health …
A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer
D Poel, EC Gootjes, L Bakkerus, W Trypsteen, H Dekker, HJ van der Vliet, ...
Cancer medicine 9 (20), 7558-7571, 2020
强制性开放获取政策： Dutch Cancer Society
cDC2 plasticity and acquisition of a DC3‐like phenotype mediated by IL‐6 and PGE2 in a patient‐derived colorectal cancer organoids model
B Subtil, IAE van der Hoorn, J Cuenca‐Escalona, AMD Becker, ...
European Journal of Immunology, 2350891, 2024
强制性开放获取政策： Netherlands Organisation for Scientific Research, Netherlands Organisation …
The neo-open reading frame peptides that comprise the tumor framome are a rich source of neoantigens for cancer immunotherapy
MV Martin, S Aguilar-Rosas, K Franke, M Pieterse, J Langelaar, ...
Cancer immunology research 12 (6), 759-778, 2024
强制性开放获取政策： European Commission
出版信息和资助信息由计算机程序自动确定